The European Commission announces the closure of its antitrust investigation in the pharmaceutical sector (Almirall/Boehringer)

On 6 July 2011, the European Commission announced that it has closed its antitrust investigation into allegations by Spanish pharmaceutical company Almirall that the German pharmaceutical company Boehringer Ingelheim filed for unmeritous patents in the area of new treatments for lung diseases and, more specifically, new treatments of chronic obstructive pulmonary disease (“COPD”). Boehringer is the market leader in the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Peter L'Ecluse, The European Commission announces the closure of its antitrust investigation in the pharmaceutical sector (Almirall/Boehringer), 6 July 2011, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 41100

Visites 164

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues